FEDERATED HERMES, INC.

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in ACRV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$14,104

+$3,090 QoQ

Shares Held

7,924

0.0% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#30

of 46 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ACRV ranks #123 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,104	7,924	0.0%	Shares	Defined	2026-08-12
2026-03-31	$11,014	7,924	+41.2%	Shares	Defined	2026-05-11
2025-12-31	$13,524	5,612	+131.3%	Shares	Defined	2026-02-12
2025-09-30	$4,391	2,426	+4.7%	Shares	Defined	2025-11-03
2025-06-30	$2,758	2,318	-99.0%	Shares	Defined	2025-08-13
2023-12-31	$1,113,765	226,375	0.0%	Shares	Defined	2024-01-31
2023-09-30	$2,164,145	226,375	-25.6%	Shares	Defined	2023-11-13
2023-06-30	$3,945,166	304,411	-50.4%	Shares	Defined	2023-08-14
2023-03-31	$7,786,901	613,625	-25.5%	Shares	Defined	2023-05-08
2022-12-31	$9,484,416	823,300	—	Shares	Defined	2023-02-13
No filing history on record for this holder in this stock.